AnnMaxineBergerMD

PubMed

• 14 citations
  A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease
  Lauren M. Curtis, Alen Ostojić, David Venzon, Noa G. Holtzman, Filip Pirsl
  Blood. 2021-02-18
• Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host disease.
  Claire L. Ruben, Filip Pirsl, Seth M. Steinberg, Noa G. Holtzman, Laura Parsons-Wandell
  Bone Marrow Transplantation. 2021-02-01
• The need for a universal language during the COVID-19 pandemic: Lessons learned from the Middle East Cancer Consortium (MECC).
  Michael Silbermann, Ann Berger
  Palliative & Supportive Care. 2020-11-20

Journal Articles

• Impact of the 2014 NIH Chronic Graft-Versus-Host Disease Scoring Criteria Modifications Assessed in a Large Cohort of Severely Affected Patients  
  Lauren M Curtis, Galen O Joe, Jacqueline W Mays, Ann Berger, Pamela Stratton, Ronald E Gress, Sandra A Mitchell, Steven Z Pavletic, Kristin Baird, Nature

Abstracts/Posters

• Factors Associated with Subsequent Cancers in Patients with Moderate or Severe Chronic Graft-Versus-Host Disease after Transplant for Hematologic Malignancy
  Ann Berger, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019